Evo Fund lowers stake in SymBio Pharmaceuticals to 33.20%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2025-10-17 14:18 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 33.20%, previous report: 33.74%.